|
WO2012000065A1
|
|
Treatment of t-cell mediated immune disorders
|
|
CA2755870A1
|
|
Production of reprogrammed pluripotent cells
|
|
WO2010025506A1
|
|
Expansion of haemopoietic precursors
|
|
CN102257388A
|
|
Monoclonal antibody stro-4
|
|
KR20110036101A
|
|
Treatment of eye diseases and excessive neovascularization using a combined therapy
|
|
KR20110037989A
|
|
Repair and/or reconstitution of invertebral discs
|
|
CN101827603A
|
|
Methods of generating, repairing and/or maintaining connective tissue in vivo
|
|
CN101516385A
|
|
Treatment of excessive neovascularization
|
|
US2008260694A1
|
|
Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof
|
|
AU2005209688A1
|
|
Mesenchymal precursor cell
|
|
US2005019911A1
|
|
Mesenchymal precursor cell
|
